Register Login

OncoCyte Corporation (OCX)

  • SEC News
  • Aug. 11, 2025, 20:10 UTC
  • 4
  • 0 comments

New Form 8-K - Insight Molecular Diagnostics Inc. Filed: 2025-08-11 AccNo: 0001641172-25-022974 Size: 702 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Comment Full text

Sana Biotechnology Inc (SANA)

  • SEC News
  • Aug. 11, 2025, 20:09 UTC
  • 4
  • 0 comments

New Form 8-K - Sana Biotechnology, Inc. Filed: 2025-08-11 AccNo: 0001770121-25-000009 Size: 523 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Comment Full text

Assertio Holdings Inc. (ASRT)

  • SEC News
  • Aug. 11, 2025, 20:09 UTC
  • 6
  • 0 comments

New Form 8-K - Assertio Holdings, Inc. Filed: 2025-08-11 AccNo: 0001808665-25-000024 Size: 514 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Comment Full text

Tempest Therapeutics Inc. (TPST)

  • SEC News
  • Aug. 11, 2025, 20:08 UTC
  • 4
  • 0 comments

New Form 8-K - Tempest Therapeutics, Inc. Filed: 2025-08-11 AccNo: 0000950170-25-106544 Size: 456 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Comment Full text

Maravai LifeSciences Holdings LLC (MRVI)

  • SEC News
  • Aug. 11, 2025, 20:07 UTC
  • 3
  • 0 comments

New Form 8-K - MARAVAI LIFESCIENCES HOLDINGS, INC. Filed: 2025-08-11 AccNo: 0001823239-25-000105 Size: 395 KB Item 2.02: Results of Operations and Financial Condition Item 2.05: Cost Associated with Exit or Disposal Activities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of …

Comment Full text

Capricor Therapeutics Inc. (CAPR)

  • SEC News
  • Aug. 11, 2025, 20:07 UTC
  • 3
  • 0 comments

New Form 8-K - CAPRICOR THERAPEUTICS, INC. Filed: 2025-08-11 AccNo: 0001558370-25-011047 Size: 334 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Comment Full text

TELA Bio Inc. (TELA)

  • SEC News
  • Aug. 11, 2025, 20:07 UTC
  • 4
  • 0 comments

New Form 8-K - TELA Bio, Inc. Filed: 2025-08-11 AccNo: 0001104659-25-076153 Size: 6 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Comment Full text

Search

News categories